With a “new normal” level of care going forward post coronavirus disease 2019 (COVID-19), the key will be to invest in high-value services while deterring a resurgence of low-value care.
Daniel A. Ollendorf, PhD
Advertisement
Articles by Daniel A. Ollendorf, PhD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on AJMC
1
Oral COVID-19 PEP May Benefit High-Risk Groups More Than General Public: Peter J. Hotez, MD
2
5 Ongoing Clinical Trials in Myeloproliferative Neoplasms
3
Defunding Co-Payment Assistance Disrupted nAMD Care
4
Aficamten Outperforms Metoprolol Across All Phases of Exercise in Obstructive HCM
5